Clinical Trial

Optokinetic Stimulation in Mal de Debarquement Syndrome: Case Report

Completed
View on ClinicalTrials.gov →
Summary
This single-case study aims to evaluate the clinical effects of optokinetic stimulation (OKS) on dizziness perception and quality of life in a patient diagnosed with Mal de Débarquement Syndrome (MdDS). The intervention follows a standardized protocol in which the patient performs head roll movements synchronized with optokinetic visual stimulation at a frequency of 0.167 Hz (10 bpm). The study is conducted online using a digital application to provide full-field optokinetic stimulation. The patient's baseline motion sickness susceptibility was characterized using the Motion Sickness Susceptibility Questionnaire-Short Form (MSSQ-SF). Primary outcome measures assessed for change from baseline include the Dizziness Handicap Inventory (DHI), Visual Analog Scale (VAS), and the Istanbul MdDS Scale
Trial Details
NCT Number NCT07304414
Lead Sponsor Istanbul Medipol University Hospital
Conditions Mal de Debarquement Syndrome (MdDS)
Enrollment 1 participants
Start Date 2025-10-24
Primary Completion 2025-10-29 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-26